Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
Источник: Nasdaq GlobeNewswire / 01 мар 2017 06:59:11 America/New_York
FRANKLIN LAKES, N.J., March 01, 2017 (GLOBE NEWSWIRE) -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it was awarded a contract worth up to $100 million with the Defense Health Agency (DHA) under the U.S. Department of Defense (DoD) for its Pyxis™ ES System. Under the purchase agreement, BD will provide its enterprise-wide medication dispensing technology platform across the DHA’s 115 military inpatient health facilities and military inpatient pharmacies.
“Through this collaboration with the DoD, we have the opportunity to help modernize the DHA’s medication management and dispensing systems across all of the organization’s facilities in the United States, Asia and Europe,” said Ranjeet Banerjee, worldwide president of Medication Management for BD. “We are honored to expand our longstanding partnership with the organization, to both upgrade existing legacy Pyxis sites to an enterprise-wide solution, as well as expand our footprint across all DHA facilities.”
Key solution areas include:
- The Pyxis ES System’s Automated Dispensing Cabinet (ADC) meets the highest quality standards for implementation at military treatment facilities across the Military Health System
- Proven pharmacy inpatient automation solution with flexibility to handle multiple architecture configurations supporting decentralized deployments
- Flexibility to consolidate configurations and scale the system via a centralized enterprise-wide platform
- Secure storage of medication and pharmaceutical items
- Provides automated system administration with tracking and management of medications
- Provides advanced data analytics and reporting capabilities
- Supports industry standard interface and integration capabilities and compatibilities
Under the terms of the agreement, BD will provide its industry leading Pyxis ES System consisting of Pyxis™ Enterprise Server, Pyxis MedStation™ ES system, Pyxis™ Smart CUBIE™ technology, and integrated analytics tools – the Knowledge Portal for Pyxis™ medication technologies. This contract award is contemplated in the company’s fiscal year 2017 guidance.
The Pyxis ES System is a scalable, web-based platform specifically designed to improve medication management across the continuum of care. The Pyxis ES platform promotes a patient-centric health care model, leveraging HIT system and Active Directory integration to enable a single health system formulary, simplified identity management and workflow enhancements. The platform enables pharmacists to manage medications remotely and eliminate redundant tasks. Nurses can readily access secured medications using safe and simple workflows that are centered on the patient.
For more information about the Pyxis Enterprise Solution, please visit: http://www.carefusion.com/pyxis.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.
Contacts: Matt Coppola BD Public Relations 201.847.7370 firstname.lastname@example.org Monique N. Dolecki BD Investor Relations 201.847.5378 email@example.com